Comparing one vs two probes for cervical treatment in HIV-positive women
Part of Cancer, Immune system & allergy, Infections, Women’s health & pregnancy clinical trials.
This study tests whether using one or two probes during thermal ablation (a heat-based treatment) works better for treating early cervical changes in women living with HIV. It aims to find the best way to prevent cervical cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Age 25 to 49 years old
- Living with HIV
- Have a cervix (not removed by surgery)
- Willing to come back for a checkup at 6 months
- Had a positive test for high-risk HPV or abnormal appearance of the cervix within the last 3 months
- Eligible for thermal ablation (a heat treatment for precancerous cells)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests two different ways to treat early cervical changes caused by HPV in women living with HIV. It compares using one heating probe versus two heating probes to destroy abnormal cervical tissue, and measures which approach works better and is easier to use.
This study tests two different approaches to treating early cervical changes in women living with HIV who tested positive for HPV (a virus that can cause cervical cancer). The goal is to see which approach works better and is easier to use in South Africa.
This study tests whether using one or two screening tools (HPV test or VIA) is better at finding cervical precancer in women with HIV. It may help improve screening and treatment for cervical cancer.
This trial tests a new way to quickly diagnose and treat cervical pre-cancer using a point-of-care device. It may help women who are HPV-positive avoid a separate treatment visit.
This study compares two treatments (Thermal Ablation and LEEP) to lower the risk of cervical cancer in women living with HIV. It aims to find which option works better and is safer for this group.
This study tests whether a chemotherapy cream (5-fluorouracil) applied after heat treatment can better prevent cervical and anal precancers in women with HIV. The goal is to improve outcomes for women in Kenya who test positive for HPV, a virus that can cause cancer.
Hear when a new HIV (Human Immunodeficiency Virus) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.